Levy C - Search Results

1

The medical management of primary sclerosing cholangitis.

Michaels A, Levy C. Michaels A, et al. Among authors: levy c. Medscape J Med. 2008 Mar 12;10(3):61. Medscape J Med. 2008. PMID: 18449341 Free PMC article. Review.

2

Current management of primary biliary cirrhosis and primary sclerosing cholangitis.

Levy C, Lindor KD. Levy C, et al. J Hepatol. 2003;38 Suppl 1:S24-37. doi: 10.1016/s0168-8278(03)00006-0. J Hepatol. 2003. PMID: 12591184 Review. No abstract available.

3

The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis.

Levy C, Lymp J, Angulo P, Gores GJ, Larusso N, Lindor KD. Levy C, et al. Dig Dis Sci. 2005 Sep;50(9):1734-40. doi: 10.1007/s10620-005-2927-8. Dig Dis Sci. 2005. PMID: 16133981 Clinical Trial.

4

Primary sclerosing cholangitis: epidemiology, natural history, and prognosis.

Levy C, Lindor KD. Levy C, et al. Semin Liver Dis. 2006 Feb;26(1):22-30. doi: 10.1055/s-2006-933560. Semin Liver Dis. 2006. PMID: 16496230 Review.

5

Primary sclerosing cholangitis--approach to diagnosis.

Steele IL, Levy C, Lindor KD. Steele IL, et al. Among authors: levy c. MedGenMed. 2007 Apr 25;9(2):20. MedGenMed. 2007. PMID: 17955076 Free PMC article. Review. No abstract available.

6

Endoscopic and surgical management of primary sclerosing cholangitis.

Michaels A, Levy C. Michaels A, et al. Among authors: levy c. Medscape J Med. 2008;10(10):242. Epub 2008 Oct 21. Medscape J Med. 2008. PMID: 19099036 Free PMC article. Review.

7

The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.

Firpi RJ, Soldevila-Pico C, Morelli GG, Cabrera R, Levy C, Clark VC, Suman A, Michaels A, Chen C, Nelson DR. Firpi RJ, et al. Among authors: levy c. Dig Dis Sci. 2010 Jan;55(1):196-203. doi: 10.1007/s10620-009-0981-3. Dig Dis Sci. 2010. PMID: 19798576 Clinical Trial.

8

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.

Levy C, Peter JA, Nelson DR, Keach J, Petz J, Cabrera R, Clark V, Firpi RJ, Morelli G, Soldevila-Pico C, Lindor K. Levy C, et al. Aliment Pharmacol Ther. 2011 Jan;33(2):235-42. doi: 10.1111/j.1365-2036.2010.04512.x. Epub 2010 Nov 17. Aliment Pharmacol Ther. 2011. PMID: 21083674

9

Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics.

Levy C, Naik J, Giordano C, Mandalia A, O'Brien C, Bhamidimarri KR, Schiff ER, Martin P. Levy C, et al. Clin Gastroenterol Hepatol. 2014 Aug;12(8):1398-405. doi: 10.1016/j.cgh.2013.12.010. Epub 2013 Dec 17. Clin Gastroenterol Hepatol. 2014. PMID: 24361417

10

Can we avoid primary sclerosing cholangitis recurrence?

Levy C. Levy C. Liver Transpl. 2016 Jan;22(1):12-3. doi: 10.1002/lt.24380. Liver Transpl. 2016. PMID: 26618603 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,933 results

Search Page

Filters